Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb study of MenACWY-TT infant schedules versus licensed MenC vaccines
2009-016841-24Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine in meningococcal disease (3 arms), sponsored by GSK. Primary endpoints: Immunogenicity of investigational vaccine components and Non-inferiority at 5 months of age. Started Mar 2010; status: completed.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2009-016841-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016841-24.